Xometry (NASDAQ:XMTR) Price Target Raised to $108.00

Posted by Francis Steltz on Nov 7th, 2026

Xometry (NASDAQ:XMTR – Free Report) had its price target increased by UBS Group from $95.00 to $108.00 in a research note published on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

Several other research firms also recently commented on XMTR. JPMorgan Chase & Co. lifted their price objective on Xometry from $120.00 to $140.00 and gave the stock an “overweight” rating in a report on Wednesday. Royal Bank Of Canada increased their target price on Xometry from $100.00 to $117.00 and gave the company a “hold” rating in a report on Wednesday. Wedbush raised their price target on Xometry from $126.00 to $140.00 and gave the stock an “outperform” rating in a research report on Wednesday. Citizens Jmp lifted their price target on Xometry from $120.00 to $135.00 and gave the stock a “market outperform” rating in a research note on Wednesday. Finally, Raymond James Financial set a $120.00 price objective on Xometry in a research report on Tuesday, September 22nd. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Xometry presently has a consensus rating of “Moderate Buy” and an average target price of $123.64.

Check Out Our Latest Research Report on XMTR

Xometry Trading Up 5.4%

Shares of XMTR stock traded up $5.94 on Wednesday, hitting $114.95. 1,101,668 shares of the company’s stock traded hands, compared to its average volume of 746,134. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.20 and a current ratio of 3.21. Xometry has a one year low of $35.86 and a one year high of $117.94. The company’s fifty day simple moving average is $98.21 and its 200 day simple moving average is $77.22. The stock has a market capitalization of $5.96 billion, a price-to-earnings ratio of -338.08 and a beta of 1.33.

Xometry (NASDAQ:XMTR – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.09. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. The business had revenue of $252.44 million during the quarter, compared to the consensus estimate of $235.54 million. During the same period in the previous year, the firm posted $0.11 earnings per share. The firm’s revenue for the quarter was up 39.5% on a year-over-year basis. Equities analysts forecast that Xometry will post -0.01 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Sanjeev Sahni sold 1,500 shares of the business’s stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $108.80, for a total transaction of $163,200.00. Following the transaction, the chief executive officer owned 178,291 shares in the company, valued at $19,398,060.80. The trade was a 0.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Randolph Altschuler sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $108.90, for a total value of $1,089,000.00. Following the completion of the sale, the director owned 531,270 shares of the company’s stock, valued at approximately $57,855,303. This trade represents a 1.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 73,199 shares of company stock valued at $7,126,855 over the last three months. Company insiders own 9.10% of the company’s stock.

Institutional Trading of Xometry

A number of institutional investors and hedge funds have recently added to or reduced their stakes in XMTR. Integrated Wealth Concepts LLC purchased a new position in Xometry during the 2nd quarter valued at $36,000. IFP Advisors Inc boosted its stake in shares of Xometry by 687.5% during the 3rd quarter. IFP Advisors Inc now owns 441 shares of the company’s stock valued at $45,000 after purchasing an additional 385 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Xometry by 74.2% during the first quarter. PNC Financial Services Group Inc. now owns 1,636 shares of the company’s stock valued at $67,000 after buying an additional 697 shares during the period. CoreCap Advisors LLC bought a new position in Xometry in the second quarter worth about $97,000. Finally, GAMMA Investing LLC raised its stake in Xometry by 36.5% in the third quarter. GAMMA Investing LLC now owns 958 shares of the company’s stock worth $99,000 after buying an additional 256 shares in the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Xometry News Roundup

Here are the key news stories impacting Xometry this week:

Positive Sentiment: Several firms—including UBS, Cantor Fitzgerald, Citizens JMP, Rosenblatt, Citigroup, JPMorgan and RBC—issued favorable outlooks or raised price targets, reinforcing expectations for further share appreciation. UBS analyst outlook Cantor Fitzgerald outlook Citizens JMP outlook Rosenblatt price target Citigroup outlook JPMorgan outlook RBC price target
Positive Sentiment: Recent Seeking Alpha commentary describes Xometry’s growth thesis as playing out and the business as powering ahead, adding to the optimistic narrative. Xometry: The Thesis Is Playing Out Xometry Powers Ahead
Positive Sentiment: A report points to GAAP profitability, a $1 billion revenue run rate and a Siemens partnership expected to support margin gains in 2027. Separately, the latest reported quarter beat analyst expectations for EPS and revenue, with revenue up 39.5% year over year. Profitability, revenue run rate and Siemens partnership report
Neutral Sentiment: The profitability outlook is not yet unambiguous: the supplied quarterly figures also show a negative net margin, so investors may look for sustained earnings improvement to validate the bullish case.

About Xometry

(Get Free Report)

Xometry, Inc (NASDAQ:XMTR) operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.